Democratizing NGS Analysis for Cell Line Development

In this webinar, Chaojie Wang, Senior Scientist at Bristol Myers Squibb (BMS), explains how his team has transformed genomic data analysis within cell line and process development by combining in-house NGS assays with Genedata Selector. You will learn how Genedata Selector Playbooks help automate sequence variant analysis workflows, improve reproducibility, and make complex bioinformatics processes accessible to non-expert users. Chaojie also demonstrates how a scalable infrastructure for NGS data generation, management, and analysis supports faster decision-making, reduces analytical bottlenecks, and enables scientists to focus on higher-value development activities 

This talk is part of Genedata’s Open Forum series on NGS-based workflows for biopharmaceutical R&D and manufacturing.